SpringWorks Therapeutics Stock (NASDAQ: SWTX) stock price, news, charts, stock research, profile.
Open | $41.270 |
Close | $41.430 |
Volume / Avg. | 572.228K / 1.120M |
Day Range | 41.080 - 42.270 |
52 Wk Range | 18.000 - 53.920 |
Market Cap | $3.069B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 17.23% |
Days to Cover | 15.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of SpringWorks Therapeutics (NASDAQ: SWTX) through any online brokerage.
Other companies in SpringWorks Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and MoonLake (NASDAQ:MLTX).
The latest price target for SpringWorks Therapeutics (NASDAQ: SWTX) was reported by HC Wainwright & Co. on Monday, May 6, 2024. The analyst firm set a price target for 74.00 expecting SWTX to rise to within 12 months (a possible 78.61% upside). 15 analyst firms have reported ratings in the last year.
The stock price for SpringWorks Therapeutics (NASDAQ: SWTX) is $41.43 last updated May 13, 2024 at 4:00 PM EDT.
There are no upcoming dividends for SpringWorks Therapeutics.
SpringWorks Therapeutics’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for SpringWorks Therapeutics.
SpringWorks Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.